• Advertise
  • About us
  • Terms and Conditions
  • Contact us
Saturday, May 17, 2025
Australian Times News
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia
No Result
View All Result
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia
No Result
View All Result
Australian Times News
No Result
View All Result
Home News

Australia secures 20-million extra AstraZeneca Covid-19 vaccines

New order will help to cover shortfall after promising vaccine trials at the University of Queensland had to be abandoned.

Mike Simpson by Mike Simpson
13-12-2020 03:00
in News
Image by Shutterbug75 from Pixabay

Image by Shutterbug75 from Pixabay

On the basis of scientific advice, the Australian Government says it has secured an additional 20-million doses of the promising AstraZeneca Covid-19 vaccine in order to strengthen the pursuit of a whole-of-population vaccination.

This will mean a total delivery of 53.8-million AstraZeneca vaccine doses in 2021, which would cover the entire population. The extra 20-million doses will be produced within the country by biotech firm CSL.

“Our advice remains that Australia remains on track for first vaccinations in March, and completion of whole of population in 2021,” Minister for Health, Greg Hunt, said.

Total of 51-million vaccines purchased

In addition, a further 11-million doses of the Novavax vaccine will be purchased, bringing the total for this vaccine to 51-million.  This provides an additional whole-of-population vaccine for Australia if proven safe and effective, Hunt stated.

A purchasing agreement is also in place for the Pfizer/BioNTech Covid-19 vaccine, with 10-million doses scheduled for early 2021.

The Australian Government is also part of the international COVAX Facility, which allows the purchases of over 25-million doses of a range of other potential vaccines.

University of Queensland trials abandoned

However, a statement by Hunt has confirmed that a promising Australian candidate for a coronavirus vaccine being trialled by CSL and the University of Queensland has been abandoned after trial participants returned false HIV-positive results.

AlsoRead...

The Predictive Infrastructure: How BOF’s Neuro Finance System Reengineers Market Forecasting

The Predictive Infrastructure: How BOF’s Neuro Finance System Reengineers Market Forecasting

5 May 2025
McGrocer opens direct access to British household brands for shoppers across Australia.

UK Grocery delivery platform McGrocer expands services to Australian Market

2 May 2025

The Federal government had previously agreed to buy 51-million doses of the vaccine. But the shortfall will now be filled by the vaccines being purchased elsewhere.

Both the university and CSL have emphasised that the positive results were false, meaning trial participants’ health was not at risk.

Not all eggs are in one vaccine basket

“As part of all clinical trials, assessments are made before expanding to the next phase of research,” Hunt explained.

“This decision is based on how the vaccine interacts with a testing system and has not been based on the safety or effectiveness of the [potential] vaccine.”

According to Hunt, Australia has deliberately not put all of its eggs in the one vaccine basket.

Tags: AstraZenecaCovid-19 in AustraliaCovid-19 vaccineUniversity of Queensland
DMCA.com Protection Status

SUBSCRIBE to our NEWSLETTER

[mc4wp_form id=”2384248″]

Don't Miss

Biela.dev is quietly becoming the Infrastructure Layer for the Next Internet

by Pauline Torongo
15 May 2025
Biela.dev is quietly becoming the Infrastructure Layer for the Next Internet
Technology

Biela.dev is not merely a consumer app; it is infrastructure. It could be a layer that powers the next generation...

Read more

The Battle for the Premier League’s Fifth Champions League Spot: Who Will Prevail?

by Fazila Olla-Logday
8 May 2025
Premier-Leagues-Fifth-Champions-League-Janosch-Diggelmann-Unsplash
at

As the Premier League season nears its climax, the race for the coveted Champions League places is tighter and more...

Read more

The Predictive Infrastructure: How BOF’s Neuro Finance System Reengineers Market Forecasting

by Pauline Torongo
5 May 2025
The Predictive Infrastructure: How BOF’s Neuro Finance System Reengineers Market Forecasting
Business & Finance

As global markets become more complex and volatile, BOF Investments has developed Neuro Finance, a predictive system that combines machine...

Read more

UK Grocery delivery platform McGrocer expands services to Australian Market

by Pauline Torongo
2 May 2025
McGrocer opens direct access to British household brands for shoppers across Australia.
Business & Finance

McGrocer, a British online grocery platform, has expanded its international reach by offering direct delivery of UK-sourced goods to Australian...

Read more

Business Gas: 3 Easy Ways to Keep Costs Down

by Fazila Olla-Logday
23 April 2025
Image Source: Unsplash
at

For many businesses, gas is one of those overheads that rarely gets much attention—until the bills start creeping up.

Read more

Top-Rated Compensation Lawyers in Brisbane: Expert Legal Help for Your Claim

by Fazila Olla-Logday
23 April 2025
Business & Finance

"🏅 Explore top-rated compensation lawyers in Brisbane! Offering expert legal help for your claim. Your victory is our priority! ⚖️💼👨‍⚖️"

Read more

The Q: Exciting New Venue will be Transformational for Queensland

by Pauline Torongo
22 April 2025
The Q: Exciting New Venue will be Transformational for Queensland
Sport

Queensland greyhound racing will embark on a new era this month when the first meeting is staged at an exciting...

Read more
Load More

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status

  • About us
  • Write for Us
  • Advertise
  • Contact us
  • T&Cs, Privacy and GDPR
No Result
View All Result
  • News
    • Weather
    • Sport
    • Technology
    • Business & Finance
      • Currency Zone
    • Lotto Results
      • The Lott
  • Lifestyle
    • Entertainment
    • Horoscopes
    • Health & Wellness
    • Recipes
  • Travel
  • Expat Life
  • Move to Australia

Copyright © Blue Sky Publications Ltd. All Rights Reserved.
australiantimes.co.uk is a division of Blue Sky Publications Ltd. Reproduction without permission prohibited. DMCA.com Protection Status